In this study, a <i>de novo</i> splicing variant (c.1652 + 5 G>A) of the <i>FOXP1</i> gene was identified in a patient with global developmental delay, mild intellectual disability, speech delay, and autistic features. This evidence concerns the gene FOXP1 and Delayed speech and language development.